| Metric | Q3 2026 | Q3 2025 |
|---|---|---|
| Revenue | 33.6 | 29.4 |
| Gross profit | 13.7 | 11.6 |
| Profit before tax | -14.5 | -17.4 |
| Net income | -14.7 | -17.8 |
| EPS (diluted, $ a share) | $-0.78 | $-1.00 |
A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.
| Revenue, year on year | +14.2% |
|---|---|
| Gross margin | 40.7% |
| Operating margin | -36.5% |
10-Q filed with the SEC, NASDAQ: OM. Figures from the filing's XBRL data; summary written with AI assistance from the filing.
Outset Medical, Inc.: key numbers
- Share price
- $3.39Close, Nov 16
- Market cap
- $64M
- Shares outstanding
- 18.87MLatest SEC cover page
- Sector
- Industrial Applications and Services
- Industry
- Electromedical & Electrotherapeutic ApparatusSIC 3845
Today's reference numbers, updated daily. Not a valuation or a recommendation.
More from Outset Medical, Inc.
All →Outset Medical Financial Results
Outset Medical reported third quarter 2026 revenue of $33.6 million, a 14% increase year-over-year, driven by strong growth in console and recurring revenue. The company reduced its net loss to $14.7 million from $17.8 million in the prior-year period while expanding gross margins to 40.7%. Management reiterated its full-year 2026 revenue guidance of $125 million to $130 million.
- Term
- Q3 2026
“Third-quarter results demonstrated continued progress against our strategic priorities and solid sales execution across both capital and recurring revenue. Consistently strong customer satisfaction and retention are expanding adoption of Tablo across our existing customer base and fueling new insourced dialysis partnerships with leading health systems. Advancing our mission to help providers nationwide improve the cost, complexity and clinical outcomes of dialysis continues to position Outset well for sustained long-term growth and value creation.”
Leslie Trigg, Chair and Chief Executive Officer
Outset Medical 10% Owner Braden Michael Leonard Buys $870K of Stock
Braden Michael Leonard, 10% Owner, bought 244,909 shares of Outset Medical, Inc. at $3.53 to $3.88 a share (average $3.55) in 2 transactions, worth $870K in total between Oct 1, 2026 and Oct 2, 2026. Shares held after the trade: 2,764,610 (+0.6%).
- Value
- $870K
- Shares
- 244,909
- Average price
- $3.55
- Role
- 10% Owner
- Holding change
- +0.6%
- Trade date
- Oct 1, 2026 to Oct 2, 2026